Leopoldo Puga, MD, FACCInterventional Cardiologist Dr. Leopoldo Puga is a distinguished Interventional Cardiologist with extensive expertise in cardiovascular diseases, interventional cardiology, ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...

Ajay M. Patel, MD, FACC, FSCAIStructural and Interventional Cardiologist Dr. Patel is a highly skilled cardiologist with a passion for improving cardiac care. He earned his medical degree from the ...

Adrian Lam appointed President and CEO of CorVista HealthDon Crawford to retire following a distinguished 42-year career in ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Heart Hospital has been awarded the American College of Cardiology’s NCDR Chest Pain – MI Registry Platinum Performance ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

With a strong legacy in healthcare and a patient-centric approach, Shanmuga Hospital Limited is poised for continued success, ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according ...

(Batesville, IN) – Effective Monday, February 24, the cardiology team from The Christ Hospital Heart and Vascular Institute will begin seeing patients at a new Batesville location, 1051 State Route ...

(Batesville, Ind.) - Effective Monday, February 24, the cardiology team from The Christ Hospital Heart and Vascular Institute will begin seeing patients at a new Batesville location, 1051 State Route ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...